Transcript The role of stakeholders in EU policy making

THE ROLE OF STAKEHOLDERS IN EU POLICY MAKING
EAMBES CONTRIBUTION TO BME IN EU
Leire Solis
Rohde Public Policy
1
BACKGROUND
• Background:
– Created in 2002 by Sebastian Rohde
– Reason: Create new approach for policy development in health policy by
including all relevant stakeholders at all stages of policy making at EU
level
• Objective: Development and positioning of health and research
topics at political level based on expert opinion and political reason
• Means: Development of long-term partnerships with policy makers,
high-level scientists and other stakeholders
• Areas of expertise: healthcare and healthcare/related areas (patient
access to therapies, research and innovation, social policy, nutrition,
disabilities, demography, market access, etc)
2
HOW WE UNDERSTAND “POLICY DEVELOPMENT”
Objective: Support development of policy based on consensus
and working for an improved regulatory and political
environment supporting better health
• Establishing political and scientific consensus
• With all parties affected, including policy makers, high-level
scientists and other stakeholders
• Encouraging our partners to extend their work to involve other
non commercial partners such as patient groups, research and
medical experts
3
IMPORTANCE OF EXTERNAL OPINION FOR POLICY
MAKING
Objective: building long-term consensus and partnerships among
different stakeholders, policy makers and the scientific
community.
• Creating new and sustainable alliances sharing similar
objectives
• Building working relationships based on expertise
• Bringing added-value and second opinions to the policymaking process
4
HEALTH POLICY = SOCIETAL POLICY
Every health topic has a great societal effect
Employment, Economics, Demography, etc.
Societal interests need to be reflected
Example: Hepatitis B
• Appears to be an infection BUT
• It actually includes:
 Health & safety at work
 Migration
 Civil liberties
Sustainable policy is limited if these groups are not included
in the development of policy
5
BME IN EU POLICIES
•
Consolidation in different policies:
–
–
–
–
To improve health
To foster innovative research
To develop a new sector with great potential for innovation
To tackle societal challenges
•
BME is now understood as being part of various fields BUT with a supportive
legislation it will develop into a recognised innovative sector on its own right
•
Example of Biotech policy and biotech sector:
•
•
•
Early 1990s: research sector part of food, plants, chemicals, health
Biotech became a sector in its own right with ability to develop into specific field of
policy and societal value
Horizontal (Biotech patents Directive) and vertical (OMP Regulation) policies
supported creation for better health, economic growth and innovation in Europe
6
EAMBES CONTRIBUTION TO BME PROMOTION
IN EU POLICIES
• Currently: Value of innovation understood by EU policy makers
• Need: concrete examples from involved actors in policy
implementation
EAMBES added value:
– Only representation of BME at EU level
– One voice for approx 8000 European experts on BME
EAMBES contribution:
– Sharing expertise and knowledge with EU decision makers and
stakeholders (i.e. public consultations)
– Working relationship with relevant EU policy makers (European
Commission, European Parliament)
– Development of policy forum for discussion of EU policy
7
Thank you for your attention
8